Dabigatran Etexilate 110 mg/1 (Dabigatran Etexilate CAPSULE) 110 mg/1

Dabigatran Etexilate 110 mg capsules are an oral medication used to prevent blood clots. This anticoagulant helps manage conditions like atrial fibrillation and deep vein thrombosis.

Strength

110 mg/1

Pack Size

60 CAPSULE in 1 BOTTLE (31722-666-60)

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dabigatran Etexilate is commonly used to reduce the risk of blood clots forming in the body. It is often prescribed for conditions such as atrial fibrillation, where irregular heartbeats can lead to clot formation. Additionally, it may be used to prevent deep vein thrombosis and pulmonary embolism in certain patients. What is Dabigatran Etexilate used for? Primarily, it helps maintain blood flow and reduce the risk of stroke in individuals with specific heart conditions.

Side Effects

Common effects of Dabigatran Etexilate may include minor bleeding, such as nosebleeds or bruising. Some users might experience stomach discomfort or heartburn. It is important to monitor for any unusual bleeding or signs of allergic reactions.

Precautions & Warnings

Handle Dabigatran Etexilate with care, especially if you have a history of bleeding disorders or kidney problems. Always follow the advice of a healthcare professional regarding its use. Store the capsules at room temperature, away from moisture and heat.

Avoid Interactions

Dabigatran Etexilate can interact with other medications, including certain pain relievers, anticoagulants, and antiplatelet drugs. It is advisable to inform your healthcare provider about all medications you are taking. Avoid consuming alcohol while using this medication, as it can increase the risk of bleeding.

Frequently Asked Questions

Dabigatran Etexilate is used to prevent blood clots in conditions like atrial fibrillation and deep vein thrombosis.

Store Dabigatran Etexilate capsules at room temperature, away from moisture and heat.

Consult your healthcare provider before combining Dabigatran Etexilate with other medications to avoid potential interactions.

Common side effects may include minor bleeding, stomach discomfort, and heartburn.

Dabigatran Etexilate may not be suitable for individuals with certain medical conditions, such as bleeding disorders or kidney problems.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.